US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Birth Control

1,403.95

+4.420.32%

Number of Gainers:3

Number of Losers:3

Number of Flat:- -

PE:- -

High:1,407.56

Open:1,403.60

Low:1,379.16

Close:1,399.52

Volume:28.35M

Turnover:218.25M

Market Cap:22.20B

Float Cap:22.06B

Loading ...

Biotech Company Femasys Inc Plunges 35.7% Following Announcement of $8 Million Public Offering

Femasys Inc. Announces $8 Million Public Offering to Fund Expansion and Product Development

Press Release: Femasys Announces Pricing of $8.0 Million Underwritten Public Offering

Acadia Pharmaceuticals Appoints Konstantina Katcheves as Chief Business and Strategy Officer

MT Newswires Live

MannKind, Backed By Blackstone, Expands Cardiorenal Focus With $360 Million Deal

Benzinga_recent_news

H.C. Wainwrights positive on MannKind deal for scPharmaceuticals

scPharmaceuticals downgraded to Hold from Buy at Maxim

MannKind’s Strategic Acquisition of scPharmaceuticals: A Catalyst for Future Growth and Value Creation

MannKind Shares Down 5.5%

THOMSON REUTERS

scPharmaceuticals Shares Gain 13% After MannKind Buyout Deal

THOMSON REUTERS

BUZZ-scPharmaceuticals rises after MannKind's buyout deal

MannKind Shares Down 1.9%

THOMSON REUTERS

scPharmaceuticals Shares Gain 13% Premarket as MannKind to Acquire Co

THOMSON REUTERS

scPharmaceuticals Announces Merger with MannKind Corporation

MannKind to acquire scPharmaceuticals for up to $6.35 per share in cash

MannKind Corporation Announces Definitive Agreement to Acquire scPharmaceuticals for $5.35 Per Share in Cash

BRIEF-MannKind To Acquire scPharmaceuticals

MannKind Corp - Deal for Upfront Cash Payment of $5.35 per Share Plus CVR

THOMSON REUTERS

MannKind Corp - Co and Blackstone Amend Financing Agreement for $175 Mln

THOMSON REUTERS

MannKind Corp - Total Equity Value $303 Mln, Deal Value up to $360 Mln

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4584/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4584","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4584\",,,,,undefined,":{"symbol":"BK4584","market":"US","secType":"PLATE","nameCN":"Birth Control","latestPrice":1403.9458,"timestamp":1756238399999,"preClose":1399.5216,"halted":0,"volume":28346237,"delay":0,"changeRate":0.003161,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":4.424194,"latestTime":"08-26 16:00:00 EDT","open":1403.5999,"high":1407.5627,"low":1379.163,"amount":218250258.219427,"amplitude":0.020292,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1756301400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.238483,"peRate":-82.243175,"turnoverRate":0.018883,"increases":3,"decrements":3,"flats":0,"marketCap":22201452825,"floatMarketCap":22055334331},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4584\",,,,,undefined,":{"symbol":"BK4584","high":1407.5627,"amplitude":0.020292,"preClose":1399.5216,"low":1379.163,"pbRate":"3.238483","latestPrice":1403.9458,"volume":28346237,"delay":0,"open":1403.5999,"prevYearClose":1682.2216,"prevWeekClose":1430.1089,"prevMonthClose":1176.7134,"prevQuarterClose":1256.7808,"fiveDayClose":1360.1963,"twentyDayClose":1255.3124,"sixtyDayClose":1265.8181,"secType":"PLATE","market":"US","turnoverRate":0.018883,"peRate":-82.243175,"marketCap":22201452825,"floatMarketCap":22055334331,"timestamp":1756238399999,"nameCN":"Birth Control"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4584\",,,,undefined,":{"bkCode":"BK4584","up":3,"down":3,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4584\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1175252042","title":"Biotech Company Femasys Inc Plunges 35.7% Following Announcement of $8 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=1175252042","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175252042?lang=en_us&edition=fundamental","pubTime":"2025-08-26 23:10","pubTimestamp":1756221055,"startTime":"0","endTime":"0","summary":"During Tuesday morning trading, shares of biotechnology company Femasys Inc (FEMY) tumbled 35.7% after the company announced a public offering to raise $8 million in capital. The proceeds from the...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FEMY","BK4082","BK4584","BK4539"],"gpt_icon":0},{"id":"2562205273","title":"Femasys Inc. Announces $8 Million Public Offering to Fund Expansion and Product Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2562205273","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562205273?lang=en_us&edition=fundamental","pubTime":"2025-08-26 11:44","pubTimestamp":1756179864,"startTime":"0","endTime":"0","summary":"Femasys Inc. has announced the pricing of an $8.0 million underwritten public offering, with the company planning to use the funds for the expansion of commercial efforts, product development, and other corporate purposes. The offering consists of 10,434,586 shares of common stock and pre-funded warrants for up to 11,750,000 shares, accompanied by common warrants for an aggregate of 22,184,586 shares. The shares and accompanying warrants are priced at $0.36 each, with certain company officers offered at a price of $0.5151. The accompanying common warrants, exercisable immediately, will expire five years from issuance. The offering is expected to close around August 27, 2025, pending customary conditions, with Jones and Laidlaw & Company  Ltd. serving as joint book-running managers.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for inform","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250826:nNDL6DCZng:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","FEMY","LU2210150020.SGD","BK4588","IE00B64PRP62.GBP","LU2095319765.USD","BK4082","BK4539","BK4112","LU0314104364.USD","LU2210149790.SGD","IE00BGHQF748.EUR","IE00BKPKM429.USD","BK4585","NDAQ","BK4584"],"gpt_icon":0},{"id":"2562205783","title":"Press Release: Femasys Announces Pricing of $8.0 Million Underwritten Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2562205783","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562205783?lang=en_us&edition=fundamental","pubTime":"2025-08-26 11:44","pubTimestamp":1756179840,"startTime":"0","endTime":"0","summary":"ATLANTA, Aug. 25, 2025  -- Femasys Inc.  , a leading biomedical innovator addressing significant unmet needs in women's health worldwide, with a broad portfolio of disruptive, accessible, in-office therapeutic and diagnostic products, today announced the pricing of an underwritten public offering of 10,434,586 shares of its common stock, or in lieu thereof, pre-funded warrants to purchase up to 11,750,000 shares of its common stock, together with accompanying common warrants to purchase up to an aggregate of 22,184,586 shares of its common stock. The combined public offering price for each share of common stock and accompanying common warrant is $0.36, except for 87,363 shares and accompanying warrants sold to certain officers of the Company at a price of $0.5151 per share and accompanying warrant. The combined offering price of each pre-funded warrant and accompanying common warrant is $0.3599. Each accompanying common warrant will have an exercise price of $0.36, except for the warra","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","BK4232","BK4584","R","BK4233","BK4539","UK","FEMY","BK4205","BK4082","BK4528"],"gpt_icon":0},{"id":"2562206192","title":"Acadia Pharmaceuticals Appoints Konstantina Katcheves as Chief Business and Strategy Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2562206192","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562206192?lang=en_us&edition=fundamental","pubTime":"2025-08-26 04:31","pubTimestamp":1756153886,"startTime":"0","endTime":"0","summary":"Acadia Pharmaceuticals (ACAD) appointed Konstantina Katcheves as senior vice president, chief business and strategy officer.Katcheves most recently served as senior vice president, global business development, at Teva Pharmaceuticals Industries (TEVA), Acadia said Monday in a statement.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4023","BK4557","LU2065170008.USD","LU2065171311.SGD","BK4231","BK4007","BK4559","BK4588","LU2065171402.SGD","LU2065169927.USD","BK4139","AKR","BK4600","BK4584","BK4596","BK4566","BK4595","BK4585","BK4516","BK4080","STRK","TEVA","ACAD"],"gpt_icon":0},{"id":"2562221915","title":"MannKind, Backed By Blackstone, Expands Cardiorenal Focus With $360 Million Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2562221915","media":"Benzinga_recent_news","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562221915?lang=en_us&edition=fundamental","pubTime":"2025-08-26 01:57","pubTimestamp":1756144620,"startTime":"0","endTime":"0","summary":"MannKind will acquire scPharmaceuticals in a $360 million deal, adding Furoscix and expanding into cardiometabolic care with a $10 billion U.S. market opportunity.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/08/25/Business-People--Double-Exposure-And-Han.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/08/25/Business-People--Double-Exposure-And-Han.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/m-a/25/08/47316036/mannkind-backed-by-blackstone-expands-cardiorenal-focus-with-360-million-deal","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4584","BK4139","MNKD"],"gpt_icon":0},{"id":"2562226525","title":"H.C. Wainwrights positive on MannKind deal for scPharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2562226525","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562226525?lang=en_us&edition=fundamental","pubTime":"2025-08-26 00:10","pubTimestamp":1756138225,"startTime":"0","endTime":"0","summary":"H.C. Wainwright reiterates a Buy rating on MannKind (MNKD) with a $9 price target saying it views the scPharmaceuticals (SCPH) acquisition positive...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/h-c-wainwrights-positive-on-mannkind-deal-for-scpharmaceuticals-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/h-c-wainwrights-positive-on-mannkind-deal-for-scpharmaceuticals-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MNKD","SCPH","BK4139","BK4007","BK4584"],"gpt_icon":0},{"id":"2562022659","title":"scPharmaceuticals downgraded to Hold from Buy at Maxim","url":"https://stock-news.laohu8.com/highlight/detail?id=2562022659","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562022659?lang=en_us&edition=fundamental","pubTime":"2025-08-26 00:05","pubTimestamp":1756137956,"startTime":"0","endTime":"0","summary":"Maxim downgraded scPharmaceuticals (SCPH) to Hold from Buy after the company agreed to be acquired by MannKind (MNKD) for $5.35 per share in cash a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scpharmaceuticals-downgraded-to-hold-from-buy-at-maxim-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scpharmaceuticals-downgraded-to-hold-from-buy-at-maxim-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","SCPH","BK4584","BK4139","MNKD"],"gpt_icon":0},{"id":"2562226300","title":"MannKind’s Strategic Acquisition of scPharmaceuticals: A Catalyst for Future Growth and Value Creation","url":"https://stock-news.laohu8.com/highlight/detail?id=2562226300","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562226300?lang=en_us&edition=fundamental","pubTime":"2025-08-26 00:05","pubTimestamp":1756137911,"startTime":"0","endTime":"0","summary":"Brandon Folkes, an analyst from H.C. Wainwright, reiterated the Buy rating on MannKind. The associated price target remains the same with $9.00. Br...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/mannkinds-strategic-acquisition-of-scpharmaceuticals-a-catalyst-for-future-growth-and-value-creation-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/mannkinds-strategic-acquisition-of-scpharmaceuticals-a-catalyst-for-future-growth-and-value-creation-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4584","MNKD","BK4139"],"gpt_icon":0},{"id":"2562247538","title":"MannKind Shares Down 5.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562247538","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562247538?lang=en_us&edition=fundamental","pubTime":"2025-08-25 21:36","pubTimestamp":1756128967,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nFWN3UH0MB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SCPH","BK4139","BK4584","MNKD","BK4007"],"gpt_icon":0},{"id":"2562247305","title":"scPharmaceuticals Shares Gain 13% After MannKind Buyout Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2562247305","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562247305?lang=en_us&edition=fundamental","pubTime":"2025-08-25 21:36","pubTimestamp":1756128967,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nFWN3UH0MB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SCPH","BK4139","BK4007","MNKD","BK4584"],"gpt_icon":0},{"id":"2562241826","title":"BUZZ-scPharmaceuticals rises after MannKind's buyout deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2562241826","media":"Reuters","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562241826?lang=en_us&edition=fundamental","pubTime":"2025-08-25 20:17","pubTimestamp":1756124258,"startTime":"0","endTime":"0","summary":"BUZZ-scPharmaceuticals rises after MannKind's buyout deal ** Shares of drugmaker scPharmaceuticals SCPH.O rise 13.2% to $5.48 premarket ** Biotech firm MannKind Corp's MNKD.O to buy scPharmaceuticals in a deal valued up to $360 million, companies say** MNKD's shares fall 2% to $4.03 premarket** Under the deal, MNKD will pay $5.35 per share upfront in cash, plus offer a non-tradable CVR worth up to $1 per share if certain regulatory and sales milestones are met** The deal will allow MannKind to expand its portfolio beyond orphan lung diseases** SCPH brings Furoscix, an FDA-approved on-body infuser to treat adults with chronic heart failure and kidney disease with over $10 billion market opportunity in U.S., according to the companies** The transaction is expected to close in Q4** Up to last close, MNKD down 36.1%, while SCPH up 37% YTD   ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nL4N3UH0R8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4584","SCPH","MNKD","BK4139","BK4007"],"gpt_icon":0},{"id":"2562249200","title":"MannKind Shares Down 1.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562249200","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562249200?lang=en_us&edition=fundamental","pubTime":"2025-08-25 20:10","pubTimestamp":1756123814,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nL4N3UH0R3:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MNKD","SCPH","BK4584","BK4139","BK4007"],"gpt_icon":0},{"id":"2562788249","title":"scPharmaceuticals Shares Gain 13% Premarket as MannKind to Acquire Co","url":"https://stock-news.laohu8.com/highlight/detail?id=2562788249","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562788249?lang=en_us&edition=fundamental","pubTime":"2025-08-25 20:10","pubTimestamp":1756123813,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nL4N3UH0R3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4584","BK4139","SCPH","BK4007","MNKD"],"gpt_icon":0},{"id":"2562249591","title":"scPharmaceuticals Announces Merger with MannKind Corporation","url":"https://stock-news.laohu8.com/highlight/detail?id=2562249591","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562249591?lang=en_us&edition=fundamental","pubTime":"2025-08-25 19:59","pubTimestamp":1756123165,"startTime":"0","endTime":"0","summary":"The latest announcement is out from scPharmaceuticals ( ($SCPH) ). On August 24, 2025, scPharmaceuticals entered into a merger agreement with MannK...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/scpharmaceuticals-announces-merger-with-mannkind-corporation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/scpharmaceuticals-announces-merger-with-mannkind-corporation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MNKD","BK4139","BK4584"],"gpt_icon":0},{"id":"2562124692","title":"MannKind to acquire scPharmaceuticals for up to $6.35 per share in cash","url":"https://stock-news.laohu8.com/highlight/detail?id=2562124692","media":"TIPRANKS","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562124692?lang=en_us&edition=fundamental","pubTime":"2025-08-25 19:35","pubTimestamp":1756121740,"startTime":"0","endTime":"0","summary":"07:32 EDT MannKind (MNKD) to acquire scPharmaceuticals (SCPH) for up to $6.35 per share in cash Published first on TheFly – the ultimate source for...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mannkind-to-acquire-scpharmaceuticals-for-up-to-6-35-per-share-in-cash-thefly-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mannkind-to-acquire-scpharmaceuticals-for-up-to-6-35-per-share-in-cash-thefly-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SCPH","BK4139","BK4007","MNKD","BK4584"],"gpt_icon":0},{"id":"2562246540","title":"MannKind Corporation Announces Definitive Agreement to Acquire scPharmaceuticals for $5.35 Per Share in Cash","url":"https://stock-news.laohu8.com/highlight/detail?id=2562246540","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562246540?lang=en_us&edition=fundamental","pubTime":"2025-08-25 19:34","pubTimestamp":1756121644,"startTime":"0","endTime":"0","summary":"MannKind Corporation announced a definitive merger agreement to acquire scPharmaceuticals Inc. MannKind will initiate a tender offer to purchase all outstanding shares of scPharmaceuticals' common stock for $5.35 per share in cash. This acquisition will integrate scPharmaceuticals' commercial and medical capabilities into MannKind's existing infrastructure. The transaction includes a strategic financing agreement with Blackstone, providing an additional $175 million to support the acquisition. Additionally, MannKind will repay and extinguish all scPharmaceuticals' outstanding debt under its credit facility with Perceptive, with the repayment and buyout amount estimated at $81 million. This move is expected to enhance MannKind's market opportunities, particularly with the potential submission of the FUROSCIX ReadyFlow Autoinjector for sNDA in Q3 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide ac","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nNDLb8Y4mv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNKD","SCPH","BK4139","BK4007","BK4584"],"gpt_icon":0},{"id":"2562324652","title":"BRIEF-MannKind To Acquire scPharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2562324652","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562324652?lang=en_us&edition=fundamental","pubTime":"2025-08-25 19:33","pubTimestamp":1756121629,"startTime":"0","endTime":"0","summary":"BRIEF-MannKind To Acquire scPharmaceuticalsAug 25 (Reuters) - MannKind Corp MNKD.O:MANNKIND TO ACQUIRE SCPHARMACEUTICALS, ACCELERATING REVENUE GROWTH AND EMERGING AS A PATIENT-CENTRIC LEADER IN CARDIO","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nTUA8WGSQS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4584","BK4007","SCPH","MNKD","BK4139"],"gpt_icon":0},{"id":"2562463482","title":"MannKind Corp - Deal for Upfront Cash Payment of $5.35 per Share Plus CVR","url":"https://stock-news.laohu8.com/highlight/detail?id=2562463482","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562463482?lang=en_us&edition=fundamental","pubTime":"2025-08-25 19:30","pubTimestamp":1756121400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nTUA8WGSQS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4584","SCPH","MNKD","BK4139"],"gpt_icon":0},{"id":"2562246557","title":"MannKind Corp - Co and Blackstone Amend Financing Agreement for $175 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2562246557","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562246557?lang=en_us&edition=fundamental","pubTime":"2025-08-25 19:30","pubTimestamp":1756121400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nTUA8WGSQS:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SCPH","BK4139","BK4584","MNKD","BK4007"],"gpt_icon":0},{"id":"2562246390","title":"MannKind Corp - Total Equity Value $303 Mln, Deal Value up to $360 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2562246390","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562246390?lang=en_us&edition=fundamental","pubTime":"2025-08-25 19:30","pubTimestamp":1756121400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nTUA8WGSQS:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4584","BK4007","MNKD","BK4139","SCPH"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":46,"code":"91000000","status":"200"}]}}